Pieris Pharmaceuticals

+$0.02 (+1.11%) As of 12:00 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PIRS and other ETFs, options, and stocks.

About PIRS

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas.

CEO
Stephen S. Yoder
Employees
141
Headquarters
Boston, Massachusetts
Founded
2001

PIRS Key Statistics

Market cap
133.34M
Price-Earnings ratio
—
Dividend yield
—
Average volume
658.92K
High today
$1.85
Low today
$1.74
Open price
$1.85
Volume
312.66K
52 Week high
$6.15
52 Week low
$1.61

PIRS News

Simply Wall StMay 16

How Many Pieris Pharmaceuticals, Inc. Shares Do Institutions Own? - Yahoo Finance

If you want to know who really controls Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), then you'll have to look at the makeup of its share registry. Generally spea

PIRS Earnings

-$0.30
-$0.22
-$0.15
-$0.07
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.11 per share
Actual
-$0.07 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure